oncology II Flashcards
selective estrogen receptor modulatorsm
- SERMs
tamoxifen
soltamox
- SERMs
tamoxifen info:
- increase risk of uterine or endometrial cancer
- QT prolongations
- increase risk of thromboembolic event
- hypo K and Mg
- hot flashes/ night sweats etc.
- decreases bone density… supplement w/ Ca and vitamin D
- teratogenic
fulvestrant
Faslodex
IM only
- selective estrogen receptor degrader (SERD)
anastrozole
Arimidex
- aromatase inhibitor
letrozole
Femara
- aromatase inhibitor
exemestane
Aromasin
- aromatase inhibitor
trastuzumab
Herceptin
need HER2 positive
- mab
gonadotropin-releasing hormone agonist
GnRH agonists
also known as luteinizing hormone-releasing hormone (LHRH) agonists, they reduce testosterone through a negative feedback mechanism, causing an initial surge in test followed by gradual reduction
- will cause decrease in bone density, sue w/ Ca and vitamin D
- tumor flare: prevent w/ concurrent sue of antiandrogent
leuprolide
Lupron Depot
- GnRH agonists
Goserelin
Zoladex
- GnRH agonists
GnRH antagonists
block GnRH directly causing a rapid decrease in testosterone productions
degarelix
firmagon
- GnRH antagonists
Relugolix
Orgovyx
- GnRH antagonists
bicalutamide
Casodex
- first gen, antiandrogens
Nilutamide
Niladron
- night blindness, DISULFIRAM reactions (avoid OH)
- first gen, antiandrogens
apalutamide
erleada
- seizures risk and QT prolongation
- second gen, antiandrogens
darolutamide
Nabeqa
- neutropenia
- second gen, antiandrogens
enzalutamide
Xtandi
- seizures risk
- second gen, antiandrogens
Abiraterone
Zytiga
- androgen biosynthesis inhibitors
BSA (m^2)
= sq root of ((Ht(cm) x Wt(kg))/ 3600)